About Us Services Careers FAQ Contact Us 0
Home Medical Devices India IVD Raw Materials Market Size, Top Share, Global Trends, Forecast to 2033

India IVD Raw Materials Market Size, Share & Trends Analysis Report By Product Type (Antibody, Antigens, Proteins, Enzymes, Biological Buffers, Substrates, Others), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunochemistry, Others), By End-User (Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, Others) and Forecasts, 2025-2033

Report Code: SRMD56521DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  2. ESG Trends
  3. ESG Trends
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Antibody
        1. By Value
      3. Antigens
        1. By Value
      4. Proteins
        1. By Value
      5. Enzymes
        1. By Value
      6. Biological Buffers
        1. By Value
      7. Substrates
        1. By Value
      8. Others
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Molecular Diagnostics
        1. By Value
      3. Clinical Chemistry
        1. By Value
      4. Immunochemistry
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Pharmaceutical & Biotechnological Companies
        1. By Value
      4. Others
        1. By Value
    5. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Antibody
          1. By Value
        3. Antigens
          1. By Value
        4. Proteins
          1. By Value
        5. Enzymes
          1. By Value
        6. Biological Buffers
          1. By Value
        7. Substrates
          1. By Value
        8. Others
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Molecular Diagnostics
          1. By Value
        3. Clinical Chemistry
          1. By Value
        4. Immunochemistry
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Pharmaceutical & Biotechnological Companies
          1. By Value
        4. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Antibody
        1. By Value
      3. Antigens
        1. By Value
      4. Proteins
        1. By Value
      5. Enzymes
        1. By Value
      6. Biological Buffers
        1. By Value
      7. Substrates
        1. By Value
      8. Others
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Molecular Diagnostics
        1. By Value
      3. Clinical Chemistry
        1. By Value
      4. Immunochemistry
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Pharmaceutical & Biotechnological Companies
        1. By Value
      4. Others
        1. By Value
    5. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Antibody
          1. By Value
        3. Antigens
          1. By Value
        4. Proteins
          1. By Value
        5. Enzymes
          1. By Value
        6. Biological Buffers
          1. By Value
        7. Substrates
          1. By Value
        8. Others
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Molecular Diagnostics
          1. By Value
        3. Clinical Chemistry
          1. By Value
        4. Immunochemistry
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Pharmaceutical & Biotechnological Companies
          1. By Value
        4. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Antibody
        1. By Value
      3. Antigens
        1. By Value
      4. Proteins
        1. By Value
      5. Enzymes
        1. By Value
      6. Biological Buffers
        1. By Value
      7. Substrates
        1. By Value
      8. Others
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Molecular Diagnostics
        1. By Value
      3. Clinical Chemistry
        1. By Value
      4. Immunochemistry
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Pharmaceutical & Biotechnological Companies
        1. By Value
      4. Others
        1. By Value
    5. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Antibody
          1. By Value
        3. Antigens
          1. By Value
        4. Proteins
          1. By Value
        5. Enzymes
          1. By Value
        6. Biological Buffers
          1. By Value
        7. Substrates
          1. By Value
        8. Others
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Molecular Diagnostics
          1. By Value
        3. Clinical Chemistry
          1. By Value
        4. Immunochemistry
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Pharmaceutical & Biotechnological Companies
          1. By Value
        4. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Antibody
        1. By Value
      3. Antigens
        1. By Value
      4. Proteins
        1. By Value
      5. Enzymes
        1. By Value
      6. Biological Buffers
        1. By Value
      7. Substrates
        1. By Value
      8. Others
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Molecular Diagnostics
        1. By Value
      3. Clinical Chemistry
        1. By Value
      4. Immunochemistry
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Pharmaceutical & Biotechnological Companies
        1. By Value
      4. Others
        1. By Value
    5. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Antibody
          1. By Value
        3. Antigens
          1. By Value
        4. Proteins
          1. By Value
        5. Enzymes
          1. By Value
        6. Biological Buffers
          1. By Value
        7. Substrates
          1. By Value
        8. Others
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Molecular Diagnostics
          1. By Value
        3. Clinical Chemistry
          1. By Value
        4. Immunochemistry
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Pharmaceutical & Biotechnological Companies
          1. By Value
        4. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Antibody
        1. By Value
      3. Antigens
        1. By Value
      4. Proteins
        1. By Value
      5. Enzymes
        1. By Value
      6. Biological Buffers
        1. By Value
      7. Substrates
        1. By Value
      8. Others
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Molecular Diagnostics
        1. By Value
      3. Clinical Chemistry
        1. By Value
      4. Immunochemistry
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Pharmaceutical & Biotechnological Companies
        1. By Value
      4. Others
        1. By Value
    5. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Antibody
          1. By Value
        3. Antigens
          1. By Value
        4. Proteins
          1. By Value
        5. Enzymes
          1. By Value
        6. Biological Buffers
          1. By Value
        7. Substrates
          1. By Value
        8. Others
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Molecular Diagnostics
          1. By Value
        3. Clinical Chemistry
          1. By Value
        4. Immunochemistry
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Pharmaceutical & Biotechnological Companies
          1. By Value
        4. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. India IVD Raw Materials Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Creative Diagnostics
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Merck KGaA
    3. Thermo Fisher Scientfic Inc.
    4. OYC Americas, Inc.
    5. Fapon Biotech Inc.
    6. Biosynth
    7. F. Hoffmann-La Roche Ltd
    8. Sysmex Corporation
    9. Shenzhen AIVD Biotechnology Co., LTD.
    10. Glentham®f Life Sciences Limited
    11. Neogen Corporation
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  4. Disclaimer
Straits Research - Access Portal
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Get Free Access


We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.